GLAND PHARMA LIMITED revenue breakdown overview

GLAND PHARMA LIMITED revenue for the last year amounted to 56.65 B INR, the most of which — 56.65 B INR — came from its highest performing source at the moment, Generic Injectibles, the year earlier bringing 36.25 B INR. The greatest contribution to the revenue figure was made by United States — last year it brought GLAND PHARMA LIMITED 26.88 B INR, and the year before that — 20.91 B INR.